Pheochromocytomas: can malignant potential be predicted?

Area of Science:

• Endocrinology
• Oncology
• Nephrology

Background:

• Malignant pheochromocytoma is rare but has a very poor prognosis.
• Metastatic lesions are the sole definitive confirmation of malignancy.
• Identifying predictive factors for malignant pheochromocytoma is essential for timely intervention.

Purpose of the Study:

• To identify predictive values for malignant pheochromocytomas.
• To compare characteristics of benign and malignant pheochromocytomas.
• To improve early detection and patient outcomes.

Main Methods:

• Retrospective analysis of 86 patients with pheochromocytomas (85 benign, 10 malignant).
• Evaluation of symptoms, diagnostic tests, treatments, and follow-up data.
• Comparison of parameters between benign and malignant tumor groups.

Main Results:

• Elevated preoperative 24-hour urinary dopamine and vanillylmandelic acid in malignant cases.
• Malignant tumors were more frequently extra-adrenal and heavier (>80g).
• Higher incidence of persistent arterial hypertension and significantly lower survival rates in malignant pheochromocytoma patients.

Conclusions:

• High urinary dopamine, extra-adrenal location, increased tumor weight, and persistent hypertension predict malignancy.
• These factors necessitate closer follow-up for early diagnosis.
• Early identification of malignant pheochromocytoma can potentially improve management strategies.